Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis.

Autor: Loo JH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore., Xu WXF; Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore., Low JT; Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore., Tay WX; Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore., Ang LS; Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore., Tam YC; Education Resource Center, Medical Board, Singapore General Hospital, Singapore 100059, Singapore., Thurairajah PH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore., Kumar R; Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore 529889, Singapore., Wong YJ; Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore 529889, Singapore.

Publikováno v: World journal of hepatology [World J Hepatol] 2022 Jun 27; Vol. 14 (6), pp. 1248-1257.